AAAAAA

   
Results: 1-25 | 26-50 | 51-59
Results: 1-25/59

Authors: Kaul, P Fu, YL Chang, WC Harrington, RA Wagner, GS Goodman, SG Granger, CB Moliterno, DJ Van de Werf, F Califf, RN Topol, EJ Armstrong, PW
Citation: P. Kaul et al., Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb, J AM COL C, 38(1), 2001, pp. 64-71

Authors: Bahit, MC Topol, EJ Califf, RM Armstrong, PW Criger, DA Hasselbad, V Betriu, A Hirsh, J Ardissino, D Granger, CB
Citation: Mc. Bahit et al., Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb. (vol 37, pg 1001, 2001), J AM COL C, 37(7), 2001, pp. 2012-2012

Authors: Bahit, MC Topol, EJ Califf, RM Armstrong, PW Criger, DA Hasselblad, V Betriu, A Hirsh, J Ardissino, D Granger, CB
Citation: Mc. Bahit et al., Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb, J AM COL C, 37(4), 2001, pp. 1001-1007

Authors: Roe, MT Ohman, EM Maas, ACP Christenson, RH Mahaffey, KW Granger, CB Harrington, RA Califf, RM Krucoff, MW
Citation: Mt. Roe et al., Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion, J AM COL C, 37(1), 2001, pp. 9-18

Authors: White, HD Simes, RJ Aylward, PEG Armstrong, PW Califf, RM French, JK Granger, CB Marschner, IC Topol, EJ Van de Werf, FJ Wilcox, RG
Citation: Hd. White et al., Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial, LANCET, 358(9296), 2001, pp. 1855-1863

Authors: Lauer, MA Houghtaling, PL Peterson, JG Granger, CB Bhatt, DL Sapp, SK Simoons, ML Harrington, RA Topol, EJ Lincoff, AM
Citation: Ma. Lauer et al., Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acutecoronary syndromes - Observations from the platelet IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 104(23), 2001, pp. 2772-2777

Authors: Fu, YL Goodman, S Chang, WC Van de Werf, F Granger, CB Armstrong, PW
Citation: Yl. Fu et al., Time to treatment influences the impact of ST-segment resolution on one-year prognosis - Insights from the Assessment of the Safety and Efficacy of aNew Thrombolytic (ASSENT-2) trial, CIRCULATION, 104(22), 2001, pp. 2653-2659

Authors: Hudson, MP Granger, CB Topol, EJ Pieper, KS Armstrong, PW Barbash, GI Guerci, AD Vahanian, A Califf, RM Ohman, EM
Citation: Mp. Hudson et al., Early reinfarction after fibrinolysis - Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (Alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies to Open occluded coronary arteries (GUSTO III) trials, CIRCULATION, 104(11), 2001, pp. 1229-1235

Authors: Barbash, GI Birnbaum, Y Bogaerts, K Hudson, M Lesaffre, E Fu, YL Goodman, S Houbracken, K Munsters, K Granger, CB Pieper, K Califf, RM Topol, EJ Van de Werf, F
Citation: Gi. Barbash et al., Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies, CIRCULATION, 103(7), 2001, pp. 954-960

Authors: Callahan, KP Malinin, AI Gurbel, PA Alexander, JH Granger, CB Serebruany, VL
Citation: Kp. Callahan et al., Platelet function and fibrinolytic agents: Two sides of a coin?, CARDIOLOGY, 95(2), 2001, pp. 55-60

Authors: Birnbaum, Y Goodman, S Barr, A Gates, KB Barbash, GI Battler, A Barbagelata, A Clemmensen, P Sgarbossa, EB Granger, CB Califf, RM Wagner, GS
Citation: Y. Birnbaum et al., Comparison of primary coronary angioplasty versus thrombolysis in patientswith ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram, AM J CARD, 88(8), 2001, pp. 842-847

Authors: Angeja, BG Alexander, JH Chin, R Li, X Barron, HV Armstrong, PW Granger, CB Van de Werf, F Gibson, CM
Citation: Bg. Angeja et al., Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-trial, AM J CARD, 88(11), 2001, pp. 1240-1245

Authors: Birnbaum, Y Criger, DA Wagner, GS Strasberg, B Mager, A Gates, K Granger, CB Ross, AM Barbash, GI
Citation: Y. Birnbaum et al., Prediction of the extent and severity of left ventricular dysfunction in anterior acute myocardial infarction by the admission electrocardiogram, AM HEART J, 141(6), 2001, pp. 915-924

Authors: Moliterno, DJ Granger, CB
Citation: Dj. Moliterno et Cb. Granger, Differences between unstable angina and acute myocardial infarction - The pathophysiological and clinical spectrum, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 135-172

Authors: Granger, CB Moliterno, DJ
Citation: Cb. Granger et Dj. Moliterno, Bedside anticoagulant testing, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 541-562

Authors: Chang, WC Fu, YL Ohman, EM Gupta, M Morris, A Roth, SN Granger, CB Califf, RM Topol, EJ Mark, DB Armstrong, PW
Citation: Wc. Chang et al., Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States, CAN J CARD, 16(10), 2000, pp. 1231-1239

Authors: Hasdai, D Granger, CB Srivatsa, SS Criger, DA Ellis, SG Califf, RM Topol, EJ Holmes, DR
Citation: D. Hasdai et al., Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy (vol 35, pg 1502, 2000), J AM COL C, 36(2), 2000, pp. 660-660

Authors: Hasdai, D Granger, CB Srivatsa, SS Criger, DA Ellis, SG Califf, RM Topol, EJ Holmes, DR
Citation: D. Hasdai et al., Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy, J AM COL C, 35(6), 2000, pp. 1502-1512

Authors: Shah, A Wagner, GS Granger, CB O'Connor, CM Green, CL Trollinger, KM Califf, RM Krucoff, MW
Citation: A. Shah et al., Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis - Reexamining the "gold standard" for myocardial reperfusion assessment, J AM COL C, 35(3), 2000, pp. 666-672

Authors: McGuire, DK Emanuelsson, H Granger, CB Ohman, EM Moliterno, DJ White, HD Ardissino, D Box, JW Califf, RM Topol, EJ
Citation: Dk. Mcguire et al., Influence of diabetes mellitus on clinical outcomes across the spectrum ofacute coronary syndromes - Findings from the GUSTO-IIb Study, EUR HEART J, 21(21), 2000, pp. 1750-1758

Authors: Topol, CE Califf, RM Simes, RJ Van de Werf, F Diaz, R Paolasso, E Aylward, PE Keech, A Klein, W Piegas, L Tomov, I Armstrong, PW Widimsky, P Grande, P Halinen, M Vahanian, A Neuhaus, K Dimas, AP Preda, I Kristinsson, A Tzivoni, D Ardissino, D White, HD Madsen, S Sugrue, D Sadowski, Z Seabra-Gomes, R Apetrei, E Dalby, A Betriu, A Pfisterer, M Verheugt, F Fox, K Bates, ER Gibler, WB Granger, CB Harrington, RA Hochman, JS Holmes, DR Kleiman, NS Lee, KL Moliterno, DJ Newby, LK Ohman, EM Califf, R Newby, K Zillman, L Lee, K Lemons, P McCourt, B Campbell, C Tardiff, B Snapp, J Bassett, K Hodgson, P Hannan, K Kandzari, L Hawkins, S Hinman-Smith, E McDougal, M Raffetto, K Thompson, D Wehrle, T Ange, C Brown, R Grissom, G Heuckel, M McCall, J Pennachi, W Spychala, M Veasey, S Pullium, M Journey, T Quintero, K Mark, D Davidson-Ray, L Diner, L Nelson, C Sowers, C Webb, G Young, M Bhapkar, M Pacchiana, C Sparapani, R Tuttle, R Weaver, D Borzak, S Douthat, L Topol, E Moliterno, D Konczos, L Baishnab, R Baishnab, R Bakos, A Blashford, L Bratsch, J Brown, K Cadorini, E Carlson, J Clemmons, P DelValle, M Drabik, M Fu, G Gates, K Gibson, Y Heil, L Hill, N Klancar, R McHale, B Montague, E Pasca, N Pergi, L Randall, R Rosso, R Sankovich, K Smith, D Wisniewski, L Witkowski, M Zovkic, V Alexander, K Bhatt, D Brener, S Campbell, L Cho, L Cole, C Deedy, M Foody, J Gassler, J Ghaffari, S Haas, G Kapadia, S Lauer, M Lauer, MS Lincoff, M Lutton, S Marso, S Mukherjee, D Patel, V Penn, M Robbins, M Roe, M Sila, C Thamilarasan, M Wagner, G Armstrong, P Bestilny, S Van de Werf, F Budts, W Graux, S Luyten, A Simes, J Keech, A Kava, M Bower, T Chan, S Crampton, L Monro, C Nayak, M Parente, G Riley, V Wilton, D Aylward, P Dolan, S Thomas, C White, H Scott, M Frye, R Alpert, J Bertrand, M Ryan, T Fisher, L Asarch, L Smith, M Lim, L Bokslag, M Chiu, P Chung, J Collins, S Dougherty, C Guimaraes, D Hakim, Z Mathieson, J Montgomery, L Novotny, B Steiner, B Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345

Authors: Ohman, EM Granger, CB Harrington, RA Lee, KL
Citation: Em. Ohman et al., Risk stratification and therapeutic decision making in acute coronary syndromes, J AM MED A, 284(7), 2000, pp. 876-878

Authors: Berger, PB Criger, DA Holmes, DR Ellis, SG Granger, CB Betriu, A Topol, EJ Califf, RM
Citation: Pb. Berger et al., Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Response, CIRCULATION, 102(4), 2000, pp. E29-E30

Authors: Fu, YL Chang, WC Mark, D Califf, RM Mackenzie, B Granger, CB Topol, EJ Hlatky, M Armstrong, PW
Citation: Yl. Fu et al., Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial - One-year follow-up of patients without ST-segment elevation, CIRCULATION, 102(12), 2000, pp. 1375-1381

Authors: Crenshaw, BS Granger, CB Birnbaum, Y Pieper, KS Morris, DC Kleiman, NS Vahanian, A Califf, RM Topol, EJ
Citation: Bs. Crenshaw et al., Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction, CIRCULATION, 101(1), 2000, pp. 27-32
Risultati: 1-25 | 26-50 | 51-59